I
NTLA//CIK 0001652130
Intellia Therapeutics, Inc.
Market Data
$11.10−$4.57 (−29.16%)
NTLA · Last trade
Prev Close
$15.67
Range (28d)
$11.10 – $17.84
Recent Filings
- 8-K291.4 KBIntellia Therapeutics, Inc.Jun 15, 8:52 AM ET·0001193125-26-270358
- 8-K212.6 KBIntellia Therapeutics, Inc.Jun 10, 4:36 PM ET·0001193125-26-265934
- 10-Q9.0 MBIntellia Therapeutics, Inc.May 11, 7:49 AM ET·0001193125-26-215740
- 8-K346.4 KBIntellia Therapeutics, Inc.May 11, 7:36 AM ET·0001193125-26-215721
- 8-K401.0 KBIntellia Therapeutics, Inc.Apr 30, 4:30 PM ET·0001193125-26-197489
- 8-K6.2 MBIntellia Therapeutics, Inc.Apr 27, 9:13 AM ET·0001193125-26-179401
- 8-K285.2 KBIntellia Therapeutics, Inc.Apr 10, 4:16 PM ET·0001193125-26-151300
- 8-K234.6 KBIntellia Therapeutics, Inc.Mar 2, 8:16 AM ET·0001193125-26-084309
- 10-K16.7 MBIntellia Therapeutics, Inc.Feb 26, 4:06 PM ET·0001193125-26-076550
- 8-K388.5 KBIntellia Therapeutics, Inc.Feb 26, 7:45 AM ET·0001193125-26-073456
Insiders
10- Atlas Venture Associates IX, LLC10% Owner
- Atlas Venture Associates IX, L.P.10% Owner
- Atlas Venture Fund IX, L.P.10% Owner
- Baker Bros. Advisors (GP) LLC10% Owner
- BAKER BROS. ADVISORS LP10% Owner
- BAKER FELIX10% Owner
- BAKER JULIAN10% Owner
- BASTA JAMESEVP, General Counsel
- Bell GraemeEVP, Chief Financial Officer
- Bermingham NessanDirector, President & CEO, 10% Owner
Tickers
Addresses
business
40 ERIE STREET SUITE 130
CAMBRIDGE, MA, 02139
mailing
40 ERIE STREET SUITE 130
CAMBRIDGE, MA, 02139